ARGS - .1739 Pre-market now at .301/.31 Argos Says Data From Phase 3 Trial Of Kidney Cancer Drug 'Supportive' of Thesis; Shares Surge 72% Pre-Bell http://stockcharts.com/c-sc/sc?s=ARGS&p=D&b=5&g=0&i=t95506281931&r=1510578953184 http://stockcharts.com/c-sc/sc?s=ARGS&p=W&b=5&g=0&i=t50081028957&r=1510579027209